Smith Thornton Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$394K Sell
3,991
-25
-0.6% -$2.61K 0.17% 100
2026
Q2
$370K Hold
4,016
– – 0.16% 104
2026
Q1
$412K Buy
4,016
+35
+0.9% +$3.95K 0.21% 98
2025
Q4
$499K Sell
3,981
-9
-0.2% -$1.15K 0.25% 82
2025
Q3
$534K Buy
3,990
+104
+3% +$13.7K 0.28% 78
2025
Q2
$529K Hold
3,886
– – 0.3% 74
2025
Q1
$515K Hold
3,886
– – 0.32% 72
2024
Q4
$440K Hold
3,886
– – 0.28% 87
2024
Q3
$443K Hold
3,886
– – 0.29% 88
2024
Q2
$404K Buy
+3,886
New +$412K 0.3% 86

Other funds holding ABT

Smith Thornton Advisors's ABT Position: Q3 2026 in Review

Smith Thornton Advisors reduced its Abbott (ABT) stake by 0.62% in Q3 2026, selling an estimated $2.61K and leaving 3,991 shares worth $394K. The position accounts for 0.17% of the portfolio, ranked #100.

Smith Thornton Advisors first reported a position in ABT in Q2 2024 and has held it in 10 quarters since. The position peaked at $534K in Q3 2025. 1,321 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • Smith Thornton Advisors held 3,991 shares of Abbott worth $394K as of Q3 2026.
  • Smith Thornton Advisors sold 25 Abbott shares in Q3 2026, an estimated $2.61K.
  • Abbott made up 0.17% of Smith Thornton Advisors's portfolio in Q3 2026, its #100 holding.
  • Smith Thornton Advisors first reported a position in Abbott in Q2 2024 and has held it in 10 quarters since.
  • Smith Thornton Advisors's Abbott position peaked at $534K in Q3 2025.
  • 1,321 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Smith Thornton Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.